HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carr, D. J. J. Articles by Blalock, J. E. Search for Related Content PubMed Articles by Carr, D. J. J. Articles by Blalock, J. E.

Opioid peptides have been shown to modulate various parameters of both the humoral and cellular arms of the immune system. The modulatory capacity of the peptides can often be substantially reduced in the presence of naloxone, an opioid receptor antagonist, indicating a classical ligand-receptor interaction. In order to characterize these interactions further, we investigated the characteristics of opioid receptors on a macrophage cell line, P388d₁. A -class opioid receptor was found with an M_r of 58 000. We also identified opioid receptors on MOLT-4 (T-cell) and IM-9 (B cell) cell lines as well as thymocytes and T celland B cell-enriched populations. Using the central (brain) -selective agonist, U-69,593, it was also determined that P388d₁ cells possess -like opioid receptors. Scatchard analysis of the binding of [³H]U-69,593 revealed a single population of sites with a dissociation constant of 17 ± 3 (S.E.M.) nmol/l and a total number of binding sites of 53·8 ± 1·0 (S.E.M.) fmol/10⁶ cells. Moreover, the racemic -selective agonist U-50,488H was able to displace 50% of [³H]U-69,593 binding at 8·0 nmol/l, whereas other opioid ligands such as [Met]-enkephalinamide (-selective) and [D-Ala²,N - Me - Phe⁴,Gly⁵ - ol] - enkephalin (µ - selective) were ineffective displacers of [³H]U-69,593 except at high concentrations.

Journal of Endocrinology (1989) 122, 161–168

This article has been cited by other articles:

				W. B. Norbury, D. N. Herndon, L. K. Branski, D. L. Chinkes, and M. G. Jeschke Urinary Cortisol and Catecholamine Excretion after Burn Injury in Children J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1270 - 1275. [Abstract] [Full Text] [PDF]

				L. F. B. P. Costa Rosa Exercise as a Time-conditioning Effector in Chronic Disease: a Complementary Treatment Strategy Evid. Based Complement. Altern. Med., June 1, 2004; 1(1): 63 - 70. [Abstract] [Full Text] [PDF]

				C. K. Hwang, C. S. Kim, H. S. Choi, S. R. McKercher, and H. H. Loh Transcriptional Regulation of Mouse {micro} Opioid Receptor Gene by PU.1 J. Biol. Chem., May 7, 2004; 279(19): 19764 - 19774. [Abstract] [Full Text] [PDF]

				I. Szabo, M. A. Wetzel, N. Zhang, A. D. Steele, D. E. Kaminsky, C. Chen, L.-Y. Liu-Chen, F. Bednar, E. E. Henderson, O. M. Z. Howard, et al. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization J. Leukoc. Biol., December 1, 2003; 74(6): 1074 - 1082. [Abstract] [Full Text]

				K. Nguyen and B. C. Miller CD28 Costimulation Induces {delta} Opioid Receptor Expression During Anti-CD3 Activation of T Cells J. Immunol., May 1, 2002; 168(9): 4440 - 4445. [Abstract] [Full Text] [PDF]

				B. M. Sharp, K. McAllen, G. Gekker, N. A. Shahabi, and P. K. Peterson Immunofluorescence Detection of {{delta}} Opioid Receptors (DOR) on Human Peripheral Blood CD4+ T Cells and DOR-Dependent Suppression of HIV-1 Expression J. Immunol., July 15, 2001; 167(2): 1097 - 1102. [Abstract] [Full Text] [PDF]

				M. A. Wetzel, A. D. Steele, T. K. Eisenstein, M. W. Adler, E. E. Henderson, and T. J. Rogers {micro}-Opioid Induction of Monocyte Chemoattractant Protein-1, RANTES, and IFN-{gamma}-Inducible Protein-10 Expression in Human Peripheral Blood Mononuclear Cells J. Immunol., December 1, 2000; 165(11): 6519 - 6524. [Abstract] [Full Text] [PDF]

				J. M. Bidlack Detection and Function of Opioid Receptors on Cells from the Immune System Clin. Vaccine Immunol., September 1, 2000; 7(5): 719 - 723. [Full Text] [PDF]

				T.S. Nandhra and R.J. Carson {beta}-endorphin inhibits the production of interleukin-8 by human chorio-decidual cells in culture Mol. Hum. Reprod., June 1, 2000; 6(6): 555 - 560. [Abstract] [Full Text] [PDF]

				M.C. Grimm, A. Ben-Baruch, D.D. Taub, O.M.Z. Howard, J.H. Resau, J.M. Wang, H. Ali, R. Richardson, R. Snyderman, and J.J. Oppenheim Opiates Transdeactivate Chemokine Receptors: delta  and µ Opiate Receptor-mediated Heterologous Desensitization J. Exp. Med., July 20, 1998; 188(2): 317 - 325. [Abstract] [Full Text] [PDF]

				T. A. Ignatowski and J. M. Bidlack Detection of Kappa Opioid Receptors on Mouse Thymocyte Phenotypic Subpopulations as Assessed by Flow Cytometry J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 298 - 306. [Abstract] [Full Text]